Focus Merit

“COVID-19 Therapeutics Accelerator” fund released


“COVID-19 Therapeutics Accelerator” is a new fund which has been released by the Bill & Melinda Gates Foundation, Wellcome and Mastercard. The $125 Million fund has been launched to upgrade technologies to fight against the COVID-19 epidemic and has been designed to identify, assess, develop and scale treatments to the COVID-19 disease outbreak. The fund targets to assess new and repurposed drugs and biologics to cure patients suffering from COVID-19 in the immediate term, and also capable of curing other viral pathogens in the future.